title: Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.
abstract: Desmosine and isodesmosine are products of elastin breakdown which are candidate biomarkers to measure lung destruction in COPD. Data exist on the burden of desmosines in urine and plasma in COPD but long-term changes have never been investigated. We determined the changes of desmosine levels over 14 months in urine and plasma of patients with type ZZ alpha-1-antitryspsin deficiency-related COPD. Urines and plasma for determination of desmosines were collected from 11 ex-smokers with moderate/severe emphysema at monthly intervals for 14 months. Spirometry and gas transfer were assessed at baseline and 6-month intervals. At baseline and month 14, eleven healthy partners of patients volunteered to give a blood sample for detection of desmosines. Desmosines were determined by capillary electrophoresis combined with laser-induced fluorescence. Urine and plasma desmosines were significantly increased after 14 months in patients (p = 0.027 and p = 0.0005, respectively). Plasma desmosines of healthy partners at baseline were 4-fold lower than from patients and not significantly different from values at month 14. Only a significant decline in lung gas transfer occurred in patients (p = 0.015). The variability of desmosines was higher in urine than in plasma (coefficient of variation 0.17 and 0.087, respectively). As longitudinal desmosine changes likely reflect the elevated elastic fiber turnover associated with the progression of lung damage and destruction in COPD, they appear to be a suitable marker for application in long-term studies. Plasma desmosines were more stable long-term biomarkers than desmosines in urine.
authors.affiliation: Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands.
authors.forename: Laura
authors.initials: L
authors.lastname: Fregonese
authors.forename: Fabio
authors.initials: F
authors.lastname: Ferrari
authors.forename: Marco
authors.initials: M
authors.lastname: Fumagalli
authors.forename: Maurizio
authors.initials: M
authors.lastname: Luisetti
authors.forename: Jan
authors.initials: J
authors.lastname: Stolk
authors.forename: Paolo
authors.initials: P
authors.lastname: Iadarola
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood / Q000652:urine; D003895:Desmosine / Q000097:blood* / Q000652:urine*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007524:Isodesmosine / Q000097:blood* / Q000652:urine*; D008297:Male; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000378:metabolism* / Q000503:physiopathology; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000378:metabolism
chemical_list: D015415:Biomarkers; C043392:SERPINA1 protein, human; D000515:alpha 1-Antitrypsin; D003895:Desmosine; D007524:Isodesmosine